Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
---|
09/09/1997 | US5665728 Administering rapamycin |
09/09/1997 | US5665723 Fibrinogen receptor antagonists |
09/09/1997 | US5665719 Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists |
09/09/1997 | US5665392 Administering anemonin pretensis powder and quinine sulfate mixture; side effect reduction |
09/09/1997 | US5665380 Lipid vesicle fusion as a method of transmitting a biologically active material to a cell |
09/09/1997 | US5665356 Human anti-Rh (D) monoclonal antibodies |
09/09/1997 | CA2016551C Thieno-triazolo-diazepine derivatives, a preparation process of the same and therapeutic compositions containing them |
09/09/1997 | CA2014521C 2-substituted n,n'-ditrimethoxybenzoyl piperazines, a preparation process of the same and therapeutic compositions containing them |
09/09/1997 | CA1339445C Recombinant hybrid immunoglobulin molecules and method of use |
09/04/1997 | WO1997031944A1 Fragments of cr1 and their use |
09/04/1997 | WO1997031939A1 Serine protease inhibitors |
09/04/1997 | WO1997031937A1 Serine protease inhibitors |
09/04/1997 | WO1997031910A1 Fibrinogen receptor antagonists |
09/04/1997 | CA2246756A1 Fibrinogen receptor antagonists |
09/04/1997 | CA2246722A1 Serine protease inhibitors |
09/04/1997 | CA2246246A1 Serine protease inhibitors |
09/03/1997 | EP0792883A1 Novel derivates of boronic acid, process for their preparation and pharmaceutical compositions containing them |
09/03/1997 | EP0792648A2 Pharmaceutical composition containing hirudin and process for its preparation |
09/03/1997 | EP0792281A1 Process for purification of factor viii |
09/03/1997 | EP0792270A1 Natriuretic cyclic compounds |
09/03/1997 | EP0792168A1 Novel tumor suppressor gene, hic-1 |
09/03/1997 | EP0792162A1 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria |
09/03/1997 | EP0792156A1 Methods for the prevention or treatment of vascular hemorrhaging and alzheimer's disease |
09/03/1997 | EP0792153A1 Compositions containing lazaroids and their use for preventing adhesions |
09/03/1997 | EP0687256B1 Hydroxymethyl furazane carboxylic acid derivatives and their use in the treatment of cardio-vascular conditions |
09/02/1997 | US5663414 Inhibits phospholipase activity; antiischemic agents; treatment of cardiac infraction |
09/02/1997 | US5663334 Process for preparing pyrimidyl imidazoles |
09/02/1997 | US5663322 Precipitation |
09/02/1997 | US5663297 Antithrombic peptides |
09/02/1997 | US5663294 Anticoagulant oligopeptides or polypeptides |
09/02/1997 | US5663172 Preventive agent for platelet aggregation |
09/02/1997 | US5663156 Mixture of higher primary aliphatic alcohols, its obtention from sugar cane wax and its pharmaceutical uses |
09/02/1997 | US5663142 For treating thrombosis, protein s deficiency, sepsis, inflammation and cancer |
09/02/1997 | US5663141 Hirudin/polyalkylene glycol conjugates and hirudin muteins |
09/02/1997 | US5663060 Having procoagulant activity |
08/28/1997 | WO1997030715A1 Method for separating cells, especially platelets, and bag assembly therefor |
08/28/1997 | WO1997026523A3 Detection of a leptin receptor variant and methods for regulating obesity |
08/28/1997 | WO1997019701A3 Glycosaminoglycan-antithrombin iii/heparin cofactor ii conjugates |
08/28/1997 | WO1997016535A3 Methods for use of mpl ligands with primitive human stem cells |
08/27/1997 | EP0791653A1 Human Fc-gamma receptor III |
08/27/1997 | EP0791359A1 Remedy for diseases caused by il-6 production |
08/27/1997 | CN1158144A Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
08/27/1997 | CN1158134A Antibodies which activate an erythropoietin receptor |
08/27/1997 | CN1158087A Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions |
08/27/1997 | CA2198576A1 Pharmaceutical composition which comprises hirudin, and process for preparing it |
08/26/1997 | US5661173 Administering an enzyme inhibitor treating diabetes |
08/26/1997 | US5661169 1-benzyl-1,3-dihydro-2H-benzimidazol-2-one derivatives, their preparation and the pharmaceutical compositions containing them |
08/26/1997 | US5661001 High molecular weight desulphatohirudin |
08/26/1997 | CA2140344C Antiinflammatory indolinyl n-hydroxyurea and n-hydroxamic acid derivatives |
08/26/1997 | CA2069931C Muscarinic receptor antagonists |
08/21/1997 | WO1997030178A2 Diagnosing trinucleotide repeat diseases and genes involved therein |
08/21/1997 | WO1997030073A1 Serine protease inhibitors |
08/21/1997 | WO1997030046A1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
08/21/1997 | WO1997030045A1 Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
08/21/1997 | WO1997029775A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist |
08/21/1997 | WO1997029774A1 Combinations, having immunosuppressive effects, containing a cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor |
08/21/1997 | WO1997029753A1 New associations of active principles containing clopidogrel and an antithrombotic agent |
08/21/1997 | WO1997014806A3 Delivery of biologically active polypeptides |
08/21/1997 | CA2634973A1 Novel benzo-1,3-dioxolyl-and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
08/21/1997 | CA2246578A1 Novel human myeloid terminal differentiation response gene |
08/21/1997 | CA2246362A1 Diagnosing trinucleotide repeat diseases and genes involved therein |
08/21/1997 | CA2246356A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist |
08/21/1997 | CA2246336A1 Combinations, having immunosuppressive effects, containing a cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor |
08/21/1997 | CA2246256A1 Serine protease inhibitors |
08/21/1997 | CA2245684A1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
08/20/1997 | EP0789777A1 Polysaccharides having a high iduronic acid content |
08/20/1997 | EP0789764A1 A novel family of protease inhibitors, and other biologic active substances |
08/20/1997 | EP0789759A1 Modified factor vii |
08/20/1997 | EP0789593A1 Yeast-based delivery vehicles |
08/20/1997 | EP0789585A1 A storage stable water solution for infusion containing a thrombin inhibitor |
08/20/1997 | EP0789583A1 Methods and kits using macrophage stimulating protein |
08/20/1997 | EP0487660B1 Treatment of thrombotic events |
08/20/1997 | CN1157619A Pyrimido £5-4-d| pyrimidines, drugs containing these compounds, their use and process for preparing them |
08/20/1997 | CN1035670C Method for preparing benzoheterocyclic compounds or its salt |
08/19/1997 | US5659063 Intermediates for amidino phenyl pyrrolidine β-alanine urea analogs |
08/19/1997 | US5658939 Prevention thrombosis in mammals |
08/19/1997 | US5658935 Useful as inhibitors of thrombocyte aggregation, the metastasis of carcinoma cells and the binding of osteoclasts on bone surfaces |
08/19/1997 | US5658929 Anticoagulants |
08/19/1997 | US5658928 Anticoagulants, antiinflammatory agents, antitumor agents,wound healing agents, osteoporosis |
08/19/1997 | US5658885 Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes |
08/19/1997 | US5658776 Generation of high titers of recombinant AAV vectors |
08/19/1997 | CA2020633C Mutant of pseudomonas, a strain yzh, and a process for producing 851 yzh nutrient solution by application of the strain |
08/14/1997 | WO1997029198A1 Thrombin muteins as antidotes for thrombin inhibitors |
08/14/1997 | WO1997029131A1 HUMAN ANTIBODIES THAT BIND HUMAN TNF$g(a) |
08/14/1997 | WO1997029128A1 GPIb-LIPID COMPLEX AND USES THEREOF |
08/14/1997 | WO1997029067A1 Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants |
08/14/1997 | DE19605126A1 Thrombinmuteine als Antidot für Thrombininhibitoren Thrombin muteins as an antidote for thrombin inhibitors |
08/14/1997 | CA2245925A1 Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants |
08/14/1997 | CA2245546A1 Thrombin muteins as antidotes for thrombin inhibitors |
08/13/1997 | EP0789021A1 Hydroxamic acid compounds as opioid kappa receptor agonists |
08/13/1997 | EP0788546A1 Nematode-extracted serine protease inhibitors and anticoagulant proteins |
08/13/1997 | EP0788510A1 Dipeptide derivatives, process for producing them and medicaments containing these compounds |
08/13/1997 | EP0788509A1 Therapeutic peptide derivatives |
08/13/1997 | EP0788491A1 6-polyfluoroalkoxy and 6-polyfluoroalkyl-2-aminobenzothiazole derivatives |
08/13/1997 | EP0583485B1 Ethanolamine derivatives having sympathomimetic and anti-pollakiuria activities |
08/13/1997 | EP0458937B1 Variants of pai-2 |
08/13/1997 | CN1156616A Chinese patent medicine for treating colporrhagia after abortion |
08/13/1997 | CN1156605A Hematopoietic Chinese medicine pill |
08/12/1997 | US5656600 Modified polypeptides |
08/12/1997 | US5656484 Genetic engineering |